| Sign In to gain access to subscriptions and/or personal tools. |
Validation of the Chinese SF-36 for quality of life assessment in patients with systemic lupus erythematosusDepartment of Rheumatology and Immunology, Tan Tock Seng Hospital, Singapore; Department of Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074. Tel: +65 772 4979; Fax: +65 779 4112.; mdctj{at}nus.edu.sg
Department of Rheumatology and Immunology, Tan Tock Seng Hospital, Singapore
Mount Elizabeth Medical Centre, Singapore
Clinical Epidemiology Unit, Tan Tock Seng Hospital, Singapore
Department of Rheumatology and Immunology, Tan Tock Seng Hospital, Singapore
Department of Medicine, National University of Singapore, Singapore We studied the reliability and validity of the Chinese Short-Form 36 Health Survey (SF-36) in a cross sectional study of patients with systemic lupus erythematosus (SLE). Sixty-nine consecutive subjects completed a questionnaire containing the Chinese SF-36 twice within 14 d. Disease activity and damage were assessed using the British Isles Lupus Activity Group (BILAG) and SLICC/ACR Damage Index (DI) scales, respectively. Internal consistency was assessed using Cronbach's alpha, reliability using Spearman's correlation and repeatability coefficients, and relationships between SF-36, BILAG and DI scores using Spearman's correlation.
The Chinese SF-36 showed high internal consistency ( These data suggest that the Chinese SF-36 is a reliable and valid measure of quality of life in patients with SLE.
Key Words: quality of life systemic lupus erythematosus language Asia Singapore
Lupus, Vol. 9, No. 9,
708-712 (2000) This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||
=0.72 0.91) and good reliability, with correlations exceeding 0.70 for 7 scales and mean scale score differences of < 2 points for 6 scales. SF-36 scores correlated weakly with BILAG scores (0.27 to 0.41) and DI scores (0.24 to 0.35), and subjects' mean SF-36 scores were 6 24 points lower than the general population, supporting construct validity of the SP-36. 
